GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $40,000 | +60.0% | 1,000 | +60.0% | 0.09% | +45.0% |
Q2 2018 | $25,000 | -26.5% | 625 | -28.6% | 0.06% | -33.3% |
Q1 2018 | $34,000 | +25.9% | 875 | +16.7% | 0.09% | +40.6% |
Q4 2017 | $27,000 | -55.0% | 750 | -49.3% | 0.06% | -39.6% |
Q3 2017 | $60,000 | -9.1% | 1,480 | -2.6% | 0.11% | 0.0% |
Q2 2017 | $66,000 | +3.1% | 1,520 | 0.0% | 0.11% | +16.5% |
Q1 2017 | $64,000 | +8.5% | 1,520 | 0.0% | 0.09% | -7.1% |
Q4 2016 | $59,000 | +11.3% | 1,520 | +23.1% | 0.10% | +5.4% |
Q3 2016 | $53,000 | -17.2% | 1,235 | -16.8% | 0.09% | -8.8% |
Q2 2016 | $64,000 | +12.3% | 1,485 | +6.1% | 0.10% | +20.0% |
Q1 2016 | $57,000 | +23.9% | 1,400 | +21.7% | 0.08% | +30.8% |
Q4 2015 | $46,000 | +4.5% | 1,150 | 0.0% | 0.06% | +4.8% |
Q3 2015 | $44,000 | +18.9% | 1,150 | +30.7% | 0.06% | +44.2% |
Q2 2015 | $37,000 | -5.1% | 880 | +3.5% | 0.04% | -8.5% |
Q1 2015 | $39,000 | 0.0% | 850 | -7.1% | 0.05% | +4.4% |
Q4 2014 | $39,000 | +62.5% | 915 | +77.7% | 0.04% | +45.2% |
Q3 2014 | $24,000 | +84.6% | 515 | +106.0% | 0.03% | +40.9% |
Q1 2014 | $13,000 | – | 250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |